Hepatocellular carcinoma tumour markers: current role and expectations.
about
Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived BiomarkersLiver resection for intermediate hepatocellular carcinomaControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaClinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis CTranslational progress on tumor biomarkersAn assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescencePrognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysisDes-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.Prognostic value of melanoma cell adhesion molecule expression in cancers: a meta-analysisOrganic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentRASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinomaHepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields.Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma.Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral HeterogeneityPreoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.Ongoing challenges in the diagnosis of hepatocellular carcinoma.Tumour-associated antigens and their anti-cancer applications.Antitumor Effect of the Mannich Base(1,3-bis-((3-Hydroxynaphthalen-2-yl)phenylmethyl)urea) on Hepatocellular Carcinoma.Hepatocellular Carcinoma: Current Questions and Future Directions.Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma.Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.Diagnostic delays are common among patients with hepatocellular carcinoma.Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian PatientslncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies.A fluorescent ELISA based on the enzyme-triggered synthesis of poly(thymine)-templated copper nanoparticles.High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients.Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.Surveillance for Hepatocellular Carcinoma.Upregulation of lncRNA Sox2ot indicates a poor prognosis for patients with hepatocellular carcinoma and promotes cell invasion.Novel Electrochemical Immunoassay for Carcinoembryonic Antigen Using Ferrocenyl Polymer Nanospheres
P2860
Q26741204-2F99A7F2-0544-4CE7-9C37-CCF6C7B45BE0Q26748756-2BFFEB78-DA15-4C50-9981-F745C806CDA9Q26772324-917C84A3-7CBD-4A39-982C-0FC2CEC4E922Q26774517-CC31A106-FDA3-4C9D-8E6E-6EA06E143CDFQ26777676-7DF8E8D4-C35D-4DD1-92F1-05D28BB72EF5Q33436257-DEF7B914-ECBD-4563-9138-740968706B79Q33668652-80F07792-560A-4C7F-9BB9-5576366221EAQ33759991-8F888FF8-BF48-4D8D-A86A-A14277249408Q33778789-1E8FE0F2-AABB-4A82-B0FC-FA73FBD30B8BQ35147875-FAB9966C-6B85-41AB-92C8-BCEDD6F9FB5FQ35835752-3914E45E-C328-46AE-8723-AC57212B42BAQ35922779-A720FF20-A679-4C69-B5AD-B2FA43A0B23CQ36782418-4FD927DE-CE43-487B-AD04-81FEACB8653AQ37031754-66238F54-D161-4FFA-9CB3-746B422D8CC3Q37197517-8183425E-3BE2-49B9-95C6-B07324C1EBC9Q37290463-72796191-5D12-4A8A-96C7-8C15B3EE8B8DQ37290515-FF0D04CB-9032-41EF-AE30-80D104AFA675Q37328031-3D84B83E-98B6-448B-A289-E1D60FBC051AQ38646886-F4A68B18-DE92-4641-84DE-35F5CFF03AA9Q38725552-599CC92A-E13C-41F0-A62C-C397F0894FEEQ38866308-7F415F53-A106-4C67-A8E9-9DBB335960D1Q38878259-4EA00BDC-61ED-491B-9512-D4C71990AE84Q38928373-6F743E96-5D36-423C-8054-15D64CFA9D5DQ38965626-DB5FC6E2-08D7-416A-85C6-7BAB49B90AA8Q40279432-F72FBCA5-FDD1-4D4B-85F7-A7F7A6FB3233Q40316507-6FF6D505-9BCB-46C6-AEF5-D5305191755AQ41708847-C9B97DC3-339E-459D-BFBB-4DEF8EB095F1Q42264428-25CF17C4-EA0A-4CBC-8325-FB362CBDDF15Q43879024-10E74C20-652D-4367-87BF-7FE9616D7790Q50227598-13F3B05F-1946-4474-8B38-4A55BC4CBEBFQ51061150-369FD7BA-CB12-40D1-99A5-0B4B9F2EC5FBQ52562123-108D37BB-F2B4-48EC-8E00-E5BC23D02138Q52649698-76C4DC0E-0051-4822-A03A-AD7A387255C9Q53187576-2EC6A48B-0265-4A56-BC2F-266750434BD1Q54857089-B30E6622-9989-431D-A7A7-395A73C37FD7Q55411864-80808E5B-B7C2-4DDA-BAC2-BD75DC03C68CQ58135272-DF7A7EE7-E4C4-4742-8FC1-79E79ECB618D
P2860
Hepatocellular carcinoma tumour markers: current role and expectations.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hepatocellular carcinoma tumour markers: current role and expectations.
@en
type
label
Hepatocellular carcinoma tumour markers: current role and expectations.
@en
prefLabel
Hepatocellular carcinoma tumour markers: current role and expectations.
@en
P1476
Hepatocellular carcinoma tumour markers: current role and expectations.
@en
P2093
Amit G Singal
Nicole Rich
P304
P356
10.1016/J.BPG.2014.07.018
P577
2014-08-22T00:00:00Z